• Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): A randomised, double-blind, placebo-controlled trial 

      Whitlock R.P., Devereaux P.J., Teoh K.H., Lamy A., Vincent J., Pogue J., Paparella D., Sessler D.I., Karthikeyan G., Villar J.C., Zuo Y., Avezum Á., Quantz M., Tagarakis G.I., Shah P.J., Abbasi S.H., Zheng H., Pettit S., Chrolavicius S., Yusuf S., SIRS Investigators (2015)
      Background Cardiopulmonary bypass initiates a systemic inflammatory response syndrome that is associated with postoperative morbidity and mortality. Steroids suppress inflammatory responses and might improve outcomes in ...